These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

383 related items for PubMed ID: 31997736

  • 21. Guidelines of care for the management of atopic dermatitis in adults with phototherapy and systemic therapies.
    Davis DMR, Drucker AM, Alikhan A, Bercovitch L, Cohen DE, Darr JM, Eichenfield LF, Frazer-Green L, Paller AS, Schwarzenberger K, Silverberg JI, Singh AM, Wu PA, Sidbury R.
    J Am Acad Dermatol; 2024 Feb; 90(2):e43-e56. PubMed ID: 37943240
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. [Therapy of atopic eczema with calcineurin inhibitors].
    Luger TA, Bieber T, Meurer M, Mrowietz U, Schwarz T, Simon J, Werfel T, Zuberbier T.
    J Dtsch Dermatol Ges; 2005 May; 3(5):385-91. PubMed ID: 16372807
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Atopic dermatitis: an evidence-based treatment update.
    Silverberg JI.
    Am J Clin Dermatol; 2014 Jul; 15(3):149-64. PubMed ID: 24464934
    [Abstract] [Full Text] [Related]

  • 26. Addressing the immunopathogenesis of atopic dermatitis: advances in topical and systemic treatment.
    Eichenfield LF, Stein Gold LF.
    Semin Cutan Med Surg; 2017 Mar; 36(2 Suppl 2):S45-S48. PubMed ID: 28654711
    [Abstract] [Full Text] [Related]

  • 27. [Systemic therapy of atopic dermatitis].
    Heratizadeh A, Breuer K, Kapp A, Werfel T.
    Hautarzt; 2003 Oct; 54(10):937-45. PubMed ID: 14513240
    [Abstract] [Full Text] [Related]

  • 28. Consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part II.
    Wollenberg A, Barbarot S, Bieber T, Christen-Zaech S, Deleuran M, Fink-Wagner A, Gieler U, Girolomoni G, Lau S, Muraro A, Czarnecka-Operacz M, Schäfer T, Schmid-Grendelmeier P, Simon D, Szalai Z, Szepietowski JC, Taïeb A, Torrelo A, Werfel T, Ring J, European Dermatology Forum (EDF), the European Academy of Dermatology and Venereology (EADV), the European Academy of Allergy and Clinical Immunology (EAACI), the European Task Force on Atopic Dermatitis (ETFAD), European Federation of Allergy and Airways Diseases Patients’ Associations (EFA), the European Society for Dermatology and Psychiatry (ESDaP), the European Society of Pediatric Dermatology (ESPD), Global Allergy and Asthma European Network (GA2LEN) and the European Union of Medical Specialists (UEMS).
    J Eur Acad Dermatol Venereol; 2018 Jun; 32(6):850-878. PubMed ID: 29878606
    [Abstract] [Full Text] [Related]

  • 29. Novel systemic drugs in treatment of atopic dermatitis: results from phase II and phase III studies published in 2017/2018.
    Werfel T.
    Curr Opin Allergy Clin Immunol; 2018 Oct; 18(5):432-437. PubMed ID: 30095475
    [Abstract] [Full Text] [Related]

  • 30. Comparison of Old and New Systemic Treatments for Moderate to Severe Atopic Dermatitis.
    Yim HJ, Jean T, Ong PY.
    Curr Allergy Asthma Rep; 2024 May; 24(5):289-301. PubMed ID: 38632138
    [Abstract] [Full Text] [Related]

  • 31. EASI p-EASI: Predicting disease severity in atopic dermatitis patients treated with dupilumab using a combination of serum biomarkers.
    Bakker DS, Ariens LFM, Giovannone B, Hijnen D, Delemarre EM, Knol E, Nierkens S, de Bruin-Weller MS, Thijs JL, Drylewicz J.
    Allergy; 2020 Dec; 75(12):3287-3289. PubMed ID: 33305359
    [No Abstract] [Full Text] [Related]

  • 32. When does atopic dermatitis warrant systemic therapy? Recommendations from an expert panel of the International Eczema Council.
    Simpson EL, Bruin-Weller M, Flohr C, Ardern-Jones MR, Barbarot S, Deleuran M, Bieber T, Vestergaard C, Brown SJ, Cork MJ, Drucker AM, Eichenfield LF, Foelster-Holst R, Guttman-Yassky E, Nosbaum A, Reynolds NJ, Silverberg JI, Schmitt J, Seyger MMB, Spuls PI, Stalder JF, Su JC, Takaoka R, Traidl-Hoffmann C, Thyssen JP, van der Schaft J, Wollenberg A, Irvine AD, Paller AS.
    J Am Acad Dermatol; 2017 Oct; 77(4):623-633. PubMed ID: 28803668
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Investigational drugs for atopic dermatitis.
    Hon KL, Leung AKC, Leung TNH, Lee VWY.
    Expert Opin Investig Drugs; 2018 Aug; 27(8):637-647. PubMed ID: 30058384
    [Abstract] [Full Text] [Related]

  • 36. The Future of Atopic Dermatitis Treatment.
    Lovell K, Patel N, Rao S, Strowd LC.
    Adv Exp Med Biol; 2024 Aug; 1447():227-244. PubMed ID: 38724797
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Dupilumab for treatment of atopic dermatitis.
    Seegräber M, Srour J, Walter A, Knop M, Wollenberg A.
    Expert Rev Clin Pharmacol; 2018 May; 11(5):467-474. PubMed ID: 29557246
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.